ENT Devices Market Size, Share & Trends Analysis Report By Product (Hearing Aids, Hearing Implants, Diagnostic ENT Devices, Surgical ENT Devices, Nasal Splints), By Region, And Segment Forecasts, 2024 - 2030

ENT Devices Market Growth & Trends


The global ENT devices market size is anticipated to reach USD 37.72 billion by 2030, growing at a CAGR of 5.54% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth can be attributed to factors such as a rising geriatric population, high prevalence of hearing loss, and increasing penetration of minimally invasive surgeries. Technological advancements in this field, an increase in healthcare investment for early detection of diseases, and favorable regulatory policies are other factors expected to drive the market’s growth.

The risk of poor immunity increases with age, making older people more vulnerable to disorders of the nose and throat. To address this issue, elderly people need regular check-ups for ENT disorders, which is leading to a rise in demand for ENT devices. According to the Royal National Institute for Deaf People (RNID), over 12 million people in the UK suffered from hearing loss. Out of these, over 40% of people were in the 50s & above, and more than 70% of people were in the 70s & above.

Hearing loss is a common chronic physical condition affecting the people of all ages. It is the third-most common condition after high blood pressure and arthritis. It is more prevalent in elder population, particularly in people over 65 years of age, and 1 in 3 people are likely to suffer from a disabling hearing loss. It can negatively impact communication and leading to depression, anxiety, social isolation, and cognitive decline. According to the National Institute on Deafness and Other Communication Disorders, 15% of the total U.S. population over 18 years of age are likely to have a hearing impairment. In addition, men are more likely to be affected with hearing loss than women.

ENT Devices Market Report Highlights
  • Based on product type, hearing aids held the largest revenue share of over 30% in 2023 and is estimated to grow at the fastest CAGR from 2024 to 2030, owing to the increasing adoption of hearing aids devices and the prevalence of hearing loss due to the growing geriatric population
  • The hearing implants segment is expected to grow at the second fastest CAGR over the forecast period. This can be attributed to the increasing adoption of hearing implants, rising awareness about cochlear implants as non-invasive procedures
  • North America dominated the market in 2023, due to several factors such as increased demand for hearing care devices, the presence of large hospital chains, highly equipped ambulatory facilities, and a significant target population
  • In February 2023, Innovia Medical launched the Summit of Medical ENT product range at BACO International 2023 held in the UK. The product range featured various premium essentials, including Ventilation Tubes and Grommets, Denver Splint, AbsorbENT Nasal and Sinus Packs, and Rhino Rocket
Please note The report will be delivered in 4-6 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. ENT Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. High prevalence of hearing loss
3.2.1.2. Growing geriatric population
3.2.1.3. Increasing penetration of minimally invasive ENT procedures
3.2.1.4. Technological advancements in ENT devices
3.2.2. Market Restraints Analysis
3.2.2.1. High cost of hearing devices
3.3. ENT Devices Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
Chapter 4. ENT Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. ENT Devices Market: Product Movement Analysis, USD Million, 2023 & 2030
4.2.1. Diagnostic ENT Devices
4.2.1.1. Diagnostic ENT Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.1.2. Rigid endoscopes
4.2.1.2.1. Rigid endoscopes market, 2018 - 2030 (USD Million)
4.2.1.2.2. Sinuscopes
4.2.1.2.2.1. Sinuscopes market, 2018 - 2030 (USD Million)
4.2.1.2.3. Otoscopes
4.2.1.2.3.1. Otoscopes market, 2018 - 2030 (USD Million)
4.2.1.2.4. Laryngoscopes
4.2.1.2.4.1. Laryngoscopes market, 2018 - 2030 (USD Million)
4.2.1.3. Flexible endoscopes
4.2.1.3.1. Flexible endoscopes market, 2018 - 2030 (USD Million)
4.2.1.3.2. Bronchoscopes
4.2.1.3.2.1. Bronchoscopes market, 2018 - 2030 (USD Million)
4.2.1.3.3. Laryngoscopes
4.2.1.3.3.1. Laryngoscopes market, 2018 - 2030 (USD Million)
4.2.1.3.4. Nasopharyngoscopes
4.2.1.3.4.1. Nasopharyngoscopes market, 2018- 2030 (USD Million)
4.2.1.4. Robot assisted endoscope
4.2.1.4.1. Robot assisted endoscope market, 2018 - 2030 (USD Million)
4.2.1.5. Hearing screening device
4.2.1.5.1. Hearing screening device market, 2018 - 2030 (USD Million)
4.2.2. Surgical ENT Devices
4.2.2.1. Surgical ENT devices market, 2018 - 2030 (USD Million)
4.2.2.2. Radiofrequency handpieces
4.2.2.2.1. Radiofrequency handpieces market, 2018 - 2030 (USD Million)
4.2.2.3. Otological drill burrs
4.2.2.3.1. Otological drill burrs market, 2018 - 2030 (USD Million)
4.2.2.4. ENT hand instruments
4.2.2.4.1. ENT hand instruments market, 2018 - 2030 (USD Million)
4.2.2.5. Sinus dilation devices
4.2.2.5.1. Sinus dilation devices market, 2018 - 2030 (USD Million)
4.2.2.6. Nasal packing devices
4.2.2.6.1. Nasal packing devices market, 2018 - 2030 (USD Million)
4.2.3. Hearing Aids
4.2.3.1. Hearing aids market, 2018 - 2030 (USD Million)
4.2.4. Hearing Implants
4.2.4.1. Hearing implants market, 2018 - 2030 (USD Million)
4.2.5. Nasal Splints
4.2.5.1. Nasal splints market, 2018 - 2030 (USD Million)
Chapter 5. ENT Devices Market: Regional Estimates & Trend Analysis
5.1. Global Regional Market Snapshot
5.2. ENT Devices Market Share, By Region, 2023 & 2030, USD Million
5.3. North America
5.3.1. North America ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. U.S.
5.3.2.1. Key country dynamics
5.3.2.2. Regulatory framework/ reimbursement structure
5.3.2.3. Competitive scenario
5.3.2.4. U.S. ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Canada
5.3.3.1. Key country dynamics
5.3.3.2. Regulatory framework/ reimbursement structure
5.3.3.3. Competitive scenario
5.3.3.4. Canada ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Europe
5.4.1. Europe ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. UK
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. UK ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Germany
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. Germany ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. France
5.4.4.1. Key country dynamics
5.4.4.2. Regulatory framework/ reimbursement structure
5.4.4.3. Competitive scenario
5.4.4.4. France ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.5. Spain
5.4.5.1. Key country dynamics
5.4.5.2. Regulatory framework/ reimbursement structure
5.4.5.3. Competitive scenario
5.4.5.4. Spain ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.6. Italy
5.4.6.1. Key country dynamics
5.4.6.2. Regulatory framework/ reimbursement structure
5.4.6.3. Competitive scenario
5.4.6.4. Italy ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.7. Denmark
5.4.7.1. Key country dynamics
5.4.7.2. Regulatory framework/ reimbursement structure
5.4.7.3. Competitive scenario
5.4.7.4. Denmark ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.8. Sweden
5.4.8.1. Key country dynamics
5.4.8.2. Regulatory framework/ reimbursement structure
5.4.8.3. Competitive scenario
5.4.8.4. Sweden ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.9. Norway
5.4.9.1. Key country dynamics
5.4.9.2. Regulatory framework/ reimbursement structure
5.4.9.3. Competitive scenario
5.4.9.4. Norway ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Asia Pacific
5.5.1. Asia Pacific ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. China
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. China ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3. Japan
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. Japan ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.4. India
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. India ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.5. South Korea
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. South Korea ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.6. Australia
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Australia ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.7. Thailand
5.5.7.1. Key country dynamics
5.5.7.2. Regulatory framework/ reimbursement structure
5.5.7.3. Competitive scenario
5.5.7.4. Thailand ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Latin America
5.6.1. Latin America ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.2. Brazil
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. Brazil ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.3. Mexico
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. Mexico ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.4. Argentina
5.6.4.1. Key country dynamics
5.6.4.2. Regulatory framework/ reimbursement structure
5.6.4.3. Competitive scenario
5.6.4.4. Argentina ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Middle East and Africa
5.7.1. Middle East and Africa ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.2. South Africa
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. South Africa ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.3. Saudi Arabia
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework/ reimbursement structure
5.7.3.3. Competitive scenario
5.7.3.4. Saudi Arabia ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.4. UAE
5.7.4.1. Key country dynamics
5.7.4.2. Regulatory framework/ reimbursement structure
5.7.4.3. Competitive scenario
5.7.4.4. UAE ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.5. Kuwait
5.7.5.1. Key country dynamics
5.7.5.2. Regulatory framework/ reimbursement structure
5.7.5.3. Competitive scenario
5.7.5.4. Kuwait ENT Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Company Market Position Analysis
6.3. Strategy Mapping
6.4. Company Profiles
6.4.1. Ambu A/S
6.4.1.1. Participant’s Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic Initiative
6.4.2. Cochlear Ltd.
6.4.2.1. Participant’s Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic Initiative
6.4.3. Demant A/S
6.4.3.1. Participant’s Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic Initiative
6.4.4. GN Store Nord A/S
6.4.4.1. Participant’s Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic Initiative
6.4.5. Karl Storz
6.4.5.1. Participant’s Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic Initiative
6.4.6. Olympus Corporation
6.4.6.1. Participant’s Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic Initiative
6.4.7. PENTAX Medical
6.4.7.1. Participant’s Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic Initiative
6.4.8. Richard Wolf GmbH
6.4.8.1. Participant’s Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic Initiative
6.4.9. Rion Co., Ltd.
6.4.9.1. Participant’s Overview
6.4.9.2. Financial Performance
6.4.9.3. Product Benchmarking
6.4.9.4. Strategic Initiative
6.4.10. Smith & Nephew plc
6.4.10.1. Participant’s Overview
6.4.10.2. Financial Performance
6.4.10.3. Product Benchmarking
6.4.10.4. Strategic Initiative
6.4.11. Sonova
6.4.11.1. Participant’s Overview
6.4.11.2. Financial Performance
6.4.11.3. Product Benchmarking
6.4.11.4. Strategic Initiative
6.4.12. Starkey Laboratories, Inc.
6.4.12.1. Participant’s Overview
6.4.12.2. Financial Performance
6.4.12.3. Product Benchmarking
6.4.12.4. Strategic Initiative
6.4.13. Stryker
6.4.13.1. Participant’s Overview
6.4.13.2. Financial Performance
6.4.13.3. Product Benchmarking
6.4.13.4. Strategic Initiative
6.4.14. Nico Corporation
6.4.14.1. Participant’s Overview
6.4.14.2. Financial Performance
6.4.14.3. Product Benchmarking
6.4.14.4. Strategic Initiative
6.4.15. Nemera.
6.4.15.1. Participant’s Overview
6.4.15.2. Financial Performance
6.4.15.3. Product Benchmarking
6.4.15.4. Strategic Initiative

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings